Myriad Genetics Announces Precise MRD Clinical Data
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular…
New Meta-Analysis Demonstrates that Access to the GeneSight
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular…
Myriad Genetics Appoints Ben Wheeler Chief Financial
SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular…
Myriad Genetics to Release Second Quarter 2025 Financial
SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular…
Myriad Genetics Earns 2025 Great Place To Work
SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular…